Variants in exon 11 of MEF2A gene and coronary artery disease: evidence from a case-control study, systematic review, and meta-analysis.

PloS One
Yan LiuWei Jin

Abstract

Coronary artery disease (CAD) is the most common heart disease worldwide. Association of CAD with variants in the myocyte enhancer factor 2A (MEF2A) gene, the first identified CAD-causing gene, has attracted special attention but the results are controversial. We aimed to evaluate this genetic association via a case-control study and meta-analysis. We performed a case-control association study to investigate the relationship between variations in exon 11 of MEF2A gene and CAD in 1045 sporadic patients and 1008 controls enrolled angiographically among southern Chinese population, and then the data from this study were compared and discussed in a systematic review and meta-analysis with all available published studies on MEF2A gene and CAD. In total, eight variants were identified (21-bp deletion, CAG repeats, CCG repeats, a CCA deletion and four SNPs). No significant link was observed between the common (CAG)(n) polymorphism and CAD, whereas the rare 21-bp deletion was detected only in five affected individuals. The meta-analysis of (CAG)(n) polymorphism and CAD risk, including nine studies with 3801 CAD patients and 4020 controls, also provided no convincing evidence for the genetic association, even upon stratification by race...Continue Reading

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Feb 12, 1998·Annals of Internal Medicine·J LauC H Schmid
Mar 17, 2001·Nature Reviews. Genetics·L R Cardon, J I Bell
Jul 17, 2003·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Maren T Scheuner
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Nov 5, 2003·Psychological Methods·Lawrence D Cohn, Betsy J Becker
Nov 5, 2003·Trends in Cardiovascular Medicine·Aldons J Lusis
Oct 22, 2004·Human Molecular Genetics·M R Krishna BhagavatulaQing Wang
Feb 18, 2005·Nature Reviews. Genetics·Joel N Hirschhorn, Mark J Daly
Apr 21, 2005·The Journal of Clinical Investigation·David Altshuler, Joel N Hirschhorn
Apr 21, 2005·The Journal of Clinical Investigation·Li WengLen A Pennacchio
Jun 3, 2005·The Journal of Clinical Investigation·Qing WangEric J Topol
Oct 1, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Kazuaki KajimotoNaoharu Iwai
Sep 22, 2006·Human Molecular Genetics·Eric J TopolQing K Wang
Jun 5, 2007·Cardiovascular Research·Anthony J WhiteBronwyn A Kingwell
Jun 21, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Yaling HanJian Kang
Nov 7, 2007·Methods in Molecular Biology·Sudha K Iyengar, Robert C Elston
Dec 19, 2007·Circulation·Wolfgang LiebJeanette Erdmann
Dec 28, 2007·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Sukru GulecNejat Akar
May 21, 2008·Current Atherosclerosis Reports·Constantin Polychronakos
Aug 16, 2008·Genomic Medicine·Yoshiji YamadaTamotsu Nishida
Jan 21, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Lung-An HsuYu-Lin Ko
Jun 2, 2009·Current Opinion in Genetics & Development·Nicholas J SchorkEric J Topol
Jun 16, 2010·European Journal of Clinical Investigation·Da-Peng DaiJian-Ping Cai
Sep 30, 2010·American Journal of Epidemiology·Orestis A PanagiotouJohn P A Ioannidis
Feb 5, 2011·Human Genetics·Jaana HartialaHooman Allayee
Apr 1, 2011·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Giuseppe MaiolinoGian Paolo Rossi
May 21, 2011·JACC. Cardiovascular Interventions·Samir B Damani, Eric J Topol
May 28, 2011·Expert Review of Cardiovascular Therapy·David EvansFrank-Ulrich Beil
Nov 5, 2014·Genetics and Molecular Research : GMR·J LiL Tian

❮ Previous
Next ❯

Citations

Nov 13, 2014·Iranian Red Crescent Medical Journal·Ali Mohammad ForoughmandKhadije Golabgirkhademi
Sep 30, 2015·Chinese Medical Journal·Ying Jiang, Hong-Bin Liu
Oct 2, 2013·European Journal of Medical Genetics·Kolsoum InanloorahatlooElahe Elahi
Apr 4, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Mélissa BeaudoinGuillaume Lettre
May 6, 2020·The Journal of International Medical Research·Yingyuan LiZhongxing Wang
Feb 9, 2021·Clinical Chemistry and Laboratory Medicine : CCLM·Qi QiaoYi-Qing Yang

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
coronary artery bypass
percutaneous
coronary
FRET

Software Mentioned

R
. stats
Haplo
Arlequin
SPSS
Review Manager
Primer3

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.